Detalhe da pesquisa
1.
Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease.
J Hepatol
; 80(3): 419-430, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37984709
2.
From Shadows to Spotlight: Exploring the Escalating Burden of Alcohol-Associated Liver Disease and Alcohol Use Disorder in Young Women.
Am J Gastroenterol
; 119(5): 893-909, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38147513
3.
Ex-vivo expanded CD34+ cell transplantation alleviates fibrotic liver injury via innate immune modulation in metabolic dysfunction-associated steatohepatitis mice.
Cytotherapy
; 2024 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38678462
4.
Profiles associated with significant hepatic fibrosis consisting of alanine aminotransferase >30 U/L, exercise habits, and metabolic dysfunction-associated steatotic liver disease.
Hepatol Res
; 2024 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38294999
5.
Metabolic management after sustained virologic response in elderly patients with hepatitis C virus: A multicenter study.
Hepatol Res
; 54(4): 326-335, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37975277
6.
Impact of non-obese metabolic dysfunction-associated fatty liver disease on risk factors for the recurrence of esophageal squamous cell carcinoma treated with endoscopic submucosal dissection: A multicenter study.
Hepatol Res
; 54(2): 201-212, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37796562
7.
Validation study of age-independent fibrosis score (Fibrosis-3 index) in patients with metabolic dysfunction-associated steatotic liver disease.
Hepatol Res
; 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38661715
8.
Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort Study.
Clin Gastroenterol Hepatol
; 21(2): 370-379, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35051649
9.
Impact of body fat accumulation on metabolic dysfunction-associated fatty liver disease and nonalcoholic fatty liver disease in Japanese male young adults.
Hepatol Res
; 53(8): 691-700, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37143429
10.
Significance of ramucirumab following atezolizumab plus bevacizumab therapy for hepatocellular carcinoma using real-world data.
Hepatol Res
; 53(2): 116-126, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36316794
11.
Agile 3+ and Agile 4, noninvasive tests for liver fibrosis, are excellent formulae to predict liver-related events in nonalcoholic fatty liver disease.
Hepatol Res
; 53(10): 978-988, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37353881
12.
Impact of metabolic dysfunction-associated fatty liver disease on the incidence of Helicobacter pylori-negative gastric cancer.
Hepatol Res
; 2023 Dec 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38156966
13.
A combination of hepatic encephalopathy and body mass index was associated with the point of no return for improving liver functional reserve after sofosbuvir/velpatasvir treatment in patients with hepatitis C virus-related decompensated cirrhosis.
Hepatol Res
; 53(1): 26-34, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36066400
14.
The beneficial impact of metabolic dysfunction-associated fatty liver disease on lenvatinib treatment in patients with non-viral hepatocellular carcinoma.
Hepatol Res
; 53(2): 104-115, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36149726
15.
Multicenter, retrospective, cohort study shows platelet counts predict hepatocellular carcinoma development in patients with nonalcoholic fatty liver disease.
Hepatol Res
; 53(5): 391-400, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36707103
16.
Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2014 to 2018 in Japan: A large-scale multicenter retrospective study.
Hepatol Res
; 53(11): 1059-1072, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37537735
17.
High intramuscular adipose tissue content was a favorable prognostic factor in patients with advanced gastric cancer treated with nivolumab monotherapy.
J Gastroenterol Hepatol
; 38(10): 1760-1767, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37225648
18.
Telephone follow-up contributes to improving adherence and treatment duration in patients with hepatocellular carcinoma treated with lenvatinib.
J Gastroenterol Hepatol
; 38(7): 1140-1147, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36880677
19.
Noninvasive tests predict liver-related events and mortality in patients with nonalcoholic fatty liver disease: sub-analysis of the CLIONE-Asia study.
J Gastroenterol Hepatol
; 38(6): 896-904, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36797989
20.
Identification of clinical phenotypes associated with poor prognosis in patients with nonalcoholic fatty liver disease via unsupervised machine learning.
J Gastroenterol Hepatol
; 38(10): 1832-1839, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37596843